Roger Finch.pdf

More documents

Recommendations

Info

The Way Forward Pharma & biotech – new antibiotics will always berequired – the need is now Diagnostics Industry– the need is great and themarket wide open; create partnerships with Pharma Healthcare – define and articulate your technologyneeds; recognise their true economic value; beprepared to pay more Licensing – encourage innovation; ensure licensingbetter supports clinical need; review approvedindications of generics to match clinical practice Governments – think globally; think strategically;build sustainable alliances; develop joined uppolicies; establish champions
The future is challenging, theproblems global but a matrixof solutions is both possibleand achievablethe future is bright… the future is brightTHE FUTURE IS YOURS
Page 1: BSAC: Celebrating 40 years of achie
Page 4 and 5: Decline in the licensing of new ant
Page 6 and 7: Development of new classesof antiba
Page 8 and 9: Streptococcus pneumoniae infections
Page 10 and 11: What pathogens/diseasesrequire new
Page 12 and 13: Strategic control of antibioticresi
Page 14 and 15: Key technology needs tosupport thes
Page 16 and 17: The EducationalChallengeUK NHS Staf
Page 18 and 19: Antimicrobial Stewardship Programme
Page 20 and 21: The advantages of better andfaster
Page 22 and 23: POC/Rapid diagnostics and drugDisad

Roger Finch.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?